A new treatment for pulmonary hypertension?

Written by: Dr John Gerry Coghlan
Published:
Edited by: Nicholas Howley

Balloon pulmonary angioplasty is a new treatment which could be suitable for patients who are unable to undergo surgery for pulmonary hypertension. We asked leading consultant cardiologist Dr John Gerry Coghlan what this new treatment involves, how long you’ll need to stay in hospital, and what the risks are.

Who is a balloon pulmonary angioplasty for?

Balloon pulmonary angioplasty is sometimes offered if you are suffering from high blood pressure in the lungs (pulmonary hypertension).

High blood pressure in the lungs is serious because it causes breathlessness and heart failure. While there are many causes of high blood pressure in the lungs, one important and potentially curable form of pulmonary hypertension is chronic thromboembolic disease – where clots in the lung arteries have failed to clear and are replaced by scar tissue.

The standard way of dealing with this is surgical removal. In about 1/3 of patients with this condition surgery is not possible, and in a proportion of those who undergo surgery, this is not successful in removing the material. These people are the ones where balloon pulmonary angioplasty can help.

How does it work?

Balloon pulmonary angioplasty works much like stenting for angina, but there are some important differences.

Firstly, nothing is left in the artery – since in the lung arteries just blowing a balloon up in the artery to move the scar aside is usually successful – and unlike the heart arteries, the vessels do not normally re-narrow after ballooning.

Secondly many more vessels need to be treated. In coronary angioplasty (usually with stenting), the cardiologist tackles 1 – 3 blockages in a maximum of 3 heart vessels. In balloon pulmonary angioplasty we treat20 – 40 narrowings in up to 20 lung territories. Because of this, we usually need to perform a number of procedures on different days, usually 3 to 4 procedures over a period of 3 to 4 months.

Once we have cleared enough blockages to allow blood to flow more easily through the lungs, the pressure in the artery falls and breathing improves.

The procedure is done under mild sedation, since it is not painful and we need you to repeatedly hold your breath (as long as possible) while working on the vessels.

What happens after the procedure?

Each procedure lasts 1 – 1.5 hours. Generally you can return to the ward immediately after the procedure.

You will be monitored for any reduction in oxygen levels, increase in heart rate or drop in blood pressure for a few hours (as these might suggest a complication has occurred). A chest x-ray is checked to ensure no fluid has leaked into the lung, then your usual anticoagulation is restarted.

If all is well you will be discharged 48 hours after the first procedure and the next day after subsequent procedures.

What are the risks?

Risks are falling as experience has been gained. From recent international registries, the rate of death is 0.5%, bleeding into the lungs 5%, and fluid into lungs also 5%. These last two are generally quite minor issues but delay discharge for a few days.

Death as a complication is getting much less frequent – but it is important to remember that we are dealing with a condition where untreated death rates of 5 - 10% per year is the rule, and this is much reduced with successful treatment. However, you should know that so far we only have enough evidence to be sure about the effect on death rates with surgery. While we gather data on the effect of BPA on improving survival, surgery will remain the preferred option.

By Dr John Gerry Coghlan
Cardiology

Dr John Gerry Coghlan is a leading consultant cardiologist based in London, who specialises in pulmonary hypertension and all aspects of cardiology, including complex breathlessness, arrhythmias, connective tissue disease (related to heart disease) and angina.

Dr Coghlan is an honorary senior lecturer at UCH London and a visiting consultant at Papworth Hospital Cambridge, where he performs balloon pulmonary angioplasty. He is also a visiting consultant at St Thomas' Hospital, Kings College Hospital, Royal United Hospital Bath, Queen Alexandra Hospital Portsmouth, Derriford Hospital Plymouth and Ulster Hospital Dundonald.

Dr Coghlan graduated from University College Dublin in 1983 and trained in cardiology at the National Cardiac Centre, Dublin, Harefield Hospital and The Royal Free Hospital, London. He is a founder member of the National Pulmonary Hypertension Physicians Association and developed the Royal Free National Pulmonary Hypertension Service.

He holds research interests in fields of pulmonary hypertension, cardiac imaging and ischaemic heart disease and has published over 200 papers in peer-reviewed journals. Throughout his career, he has won awards such as the Molloy prize in 1978 and a silver medal in surgery in 1983, amongst others.

View Profile

Overall assessment of their patients


  • Related procedures
  • Heart attack
    Arrhythmia
    Hypertension (high blood pressure)
    Pericarditis
    Heart failure
    Injury valves
    Heart murmur
    Echocardiogram
    Electrocardiogram
    Ambulatory electrocardiogram (Holter)
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.